Is Advanced Enzyme Technologies a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Advanced Enzyme Technologies Ltd is a good quality company .

Is Advanced Enzyme Technologies undervalued or overvalued?

The key valuation ratios of Advanced Enzyme Technologies Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Advanced Enzyme Technologies share price return in the past 10 years?

Data is not available for this company

Is Advanced Enzyme Technologies a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Advanced Enzyme Technologies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Advanced Enzyme Technologies?

The latest standalone P/E ratio of Advanced Enzyme Technologies as of 26-Dec-2024 is 40.40.

What is the P/B ratio of Advanced Enzyme Technologies?

The latest standalone P/B ratio of Advanced Enzyme Technologies as of 26-Dec-2024 is 6.60.

What is the 52-week high and low of Advanced Enzyme Technologies?

The 52-week high of Advanced Enzyme Technologies is Rs. 571.15 and the 52-week low is Rs. 334.05.

Advanced Enzyme Technologies Ltd - Stock Valuation and Financial Performance

Name: Advanced Enzyme Technologies
Brand: Advanced Enzyme Technologies

BSE: 540025 | NSE: ADVENZYMES | Pharmaceuticals & Drugs | Small Cap

Place order

Advanced Enzyme Share Price

₹354.05 -1.40 -0.39%
as on 26-Dec'24 16:59

10 Year X-Ray of Advanced Enzyme:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	13.8%	14.3%	18.1%	15.1%	14.9%	21.5%	24.2%	15.8%	14.8%	24.3%	-
Value Creation Index ⓘ	0.0	0.0	0.3	0.1	0.1	0.5	0.7	0.1	0.1	0.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	126	139	173	212	222	247	283	273	312	365	347
Sales YoY Gr.	-	10.5%	24.1%	22.8%	4.7%	11.4%	14.6%	-3.8%	14.2%	17.3%	-
Adj EPS ⓘ	1.8	2	3.1	3.2	3.2	5.2	6.3	4.8	5	10.8	8.8
YoY Gr.	-	11.2%	58.1%	1.9%	-0.9%	64.6%	21.7%	-24.2%	3.3%	118.4%	-
BVPS (₹) ⓘ	14.3	16	22.8	25.6	28.3	32.9	38.7	42.9	47	51.6	53.8
Adj Net Profit ⓘ	19.3	21.6	34.9	35.6	35.3	58.1	70.7	53.7	55.5	121	98
Cash Flow from Ops. ⓘ	33.5	22.3	21.1	22.6	35.4	46	84.2	37.1	50.3	55.8	-
Debt/CF from Ops. ⓘ	1.2	2.2	1.8	2	0.6	0.2	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	12.6%	10.5%	8.8%	17.3%
Adj EPS ⓘ	22.2%	27.9%	19.6%	118.4%
BVPSⓘ	15.3%	12.8%	10.1%	9.9%
Share Price	-	16.7%	2%	-7.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	13.2	13.1	16.3	13.1	11.6	16.8	17.6	11.7	11	21.9	16.7
Op. Profit Mgn % ⓘ	27	26.8	28.4	23.3	23.9	31.5	35.7	26.7	24.4	28.8	25.4
Net Profit Mgn % ⓘ	15.4	15.5	20.2	16.8	15.9	23.5	25	19.7	17.8	33.1	28.4
Debt to Equity ⓘ	0.3	0.3	0.2	0.2	0.1	0	0	0	0	0	0
Working Cap Days ⓘ	236	224	199	205	234	223	203	230	220	194	136
Cash Conv. Cycle ⓘ	142	134	125	113	113	120	106	124	126	128	112

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 16.70%

Net Profit is growing at healthy rate in last 3 years 19.60%

Sales growth has been subdued in last 3 years 8.84%

Sales growth is not so good in last 4 quarters at 1.78%

Latest Financials - Advanced Enzyme Technologies Ltd.

	Standalone	Consolidated
TTM EPS (₹)	8.8	12.3
TTM Sales (₹ Cr.)	347	619
BVPS (₹.) ⓘ	53.8	119.9
Reserves (₹ Cr.) ⓘ	580	1,319
P/BV ⓘ	6.60	2.96
PE ⓘ	40.40	29.01

From the Market
52 Week Low / High (₹)	334.05 / 571.15
All Time Low / High (₹)	91.05 / 571.15
Market Cap (₹ Cr.)	3,977
Equity (₹ Cr.)	22.4
Face Value (₹)	2
Industry PE ⓘ	44.4

Management X-Ray of Advanced Enzyme:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Advanced Enzyme

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Advanced Enzyme

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	126	139	173	212	222	247	283	273	312	365
Operating Expenses ⓘ	92	103	124	163	169	170	183	200	236	260
Manufacturing Costs	19	19	18	19	18	20	21	30	34	41
Material Costs	37	44	62	86	86	89	96	99	123	132
Employee Cost	19	24	27	32	33	33	34	39	41	50
Other Costs ⓘ	17	16	17	26	33	29	31	32	38	37
Operating Profit ⓘ	34	36	49	49	53	77	101	73	75	105
Operating Profit Margin (%)	26.8%	26.1%	28.1%	23.3%	23.8%	31.1%	35.6%	26.7%	24.1%	28.8%
Other Income ⓘ	1	1	6	6	6	9	7	9	10	59
Interest ⓘ	5	4	3	3	3	1	0	0	0	0
Depreciation ⓘ	8	7	8	8	9	9	9	10	10	11
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	-19
Profit Before Tax ⓘ	22	25	44	44	47	76	98	72	74	134
Tax ⓘ	3	5	9	8	12	18	27	18	19	26
Profit After Tax	19	21	35	36	35	58	71	55	56	108
PAT Margin (%)	15.3%	15.0%	20.0%	16.9%	15.9%	23.4%	25.1%	20.0%	17.8%	29.6%
Adjusted EPS (₹)	1.8	1.9	3.1	3.2	3.2	5.2	6.4	4.9	5.0	9.7
Dividend Payout Ratio (%)	6%	10%	13%	16%	19%	12%	14%	21%	20%	53%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	156	174	255	286	316	367	433	480	525	577
Share Capital ⓘ	22	22	22	22	22	22	22	22	22	22
Reserves ⓘ	134	152	233	264	294	345	410	457	503	555
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	28	45	33	40	18	9	0	0	0	0
Long Term Debt	5	16	12	8	2	1	0	0	0	0
Short Term Debt	22	29	21	32	17	8	0	0	0	0
Trade Payables	8	9	8	21	16	14	23	20	18	22
Others Liabilities ⓘ	31	32	21	25	26	33	34	30	32	34
Total Liabilities ⓘ	222	261	318	373	376	423	490	530	576	633
Fixed Assets
Gross Block	167	170	107	114	122	160	174	183	204	213
Accumulated Depreciation	62	69	8	16	24	33	42	51	61	71
Net Fixed Assetsⓘ	106	101	98	98	97	127	132	132	143	142
CWIP ⓘ	4	7	8	10	7	10	7	9	11	22
Investmentsⓘ	27	53	103	120	120	121	184	189	201	256
Inventories	39	47	51	55	59	60	63	80	77	97
Trade Receivables	25	23	31	39	38	52	55	49	67	75
Cash Equivalents	1	2	1	0	1	3	2	18	25	19
Others Assetsⓘ	20	28	25	51	54	50	46	52	52	22
Total Assets ⓘ	222	261	318	373	376	423	490	530	576	633

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	33	22	21	23	35	46	84	37	50	56
PBT ⓘ	22	25	44	44	47	76	98	72	74	134
Adjustment ⓘ	14	11	6	9	7	3	4	2	5	-24
Changes in Working Capital ⓘ	3	-9	-19	-21	-6	-20	9	-15	-13	-27
Tax Paid ⓘ	-6	-6	-10	-9	-12	-13	-27	-21	-16	-27
Cash Flow From Investing Activity ⓘ	-7	-27	-55	-22	-2	-25	-70	-14	-42	-7
Capex	-4	-1	-7	-7	-4	-41	-9	-9	-23	-21
Net Investments	-1	-26	-50	-16	0	-1	-63	-9	-22	-40
Others ⓘ	-2	1	3	2	2	17	3	4	3	54
Cash Flow From Financing Activityⓘ	-27	4	34	-1	-33	-19	-15	-11	-12	-57
Net Proceeds from Shares ⓘ	0	0	47	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-13	4	-3	-4	-9	-1	-2	0	0	0
Interest Paid ⓘ	-4	-4	-3	-3	-2	-1	0	0	0	0
Dividend Paid ⓘ	-1	-3	0	-5	-6	-8	-7	-10	-11	-56
Others ⓘ	-9	7	-8	11	-16	-9	-7	-1	-1	-1
Net Cash Flow ⓘ	-1	0	0	0	0	2	-1	12	-4	-8

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	13.13	12.66	16.11	13.26	11.7	16.98	17.76	11.95	11.05	19.61
ROCE (%)	13.84	14.31	18.06	15.07	14.85	21.45	24.16	15.78	14.83	24.3
Asset Turnover Ratio	0.59	0.62	0.64	0.62	0.59	0.62	0.63	0.54	0.57	0.61
PAT to CFO Conversion(x)	1.74	1.05	0.6	0.64	1	0.79	1.18	0.67	0.89	0.52
Working Capital Days
Receivable Days	73	58	53	59	63	66	68	69	68	71
Inventory Days	104	107	98	90	93	87	78	96	92	87
Payable Days	82	69	51	63	78	60	69	79	57	55

Advanced Enzyme Technologies Ltd Stock News

Advanced Enzyme Technologies Ltd FAQs

What is the share price of Advanced Enzyme?

Company share prices are keep on changing according to the market conditions. The closing price of Advanced Enzyme on 26-Dec-2024 16:59 is ₹354.1.

What is the market cap of Advanced Enzyme?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 26-Dec-2024 16:59 the market cap of Advanced Enzyme stood at ₹3,976.8.

What is the P/E ratio of Advanced Enzyme?

The latest P/E ratio of Advanced Enzyme as of 26-Dec-2024 16:59 is 40.40.

What is the P/B ratio of Advanced Enzyme?

The latest P/B ratio of Advanced Enzyme as of 26-Dec-2024 16:59 is 6.60.

What is the 52-week high and low of Advanced Enzyme?

The 52-week high of Advanced Enzyme is ₹571.1 and the 52-week low is ₹334.1.

What is the TTM revenue of Advanced Enzyme?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Advanced Enzyme is ₹346.9 ( Cr.) .

About Advanced Enzyme Technologies Ltd

The company was incorporated as a private limited company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a special resolution passed by the shareholders of the Company at the extra-ordinary general meeting held on April 21, 1992, the Company was converted into a public limited company and consequently the name of the Company was changed to Advanced Biochemicals Limited. A fresh certificate of change of name reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a special resolution passed by the shareholders of their Company at the extra-ordinary general meeting held on August 8, 2005, the name of Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19, 2005.

Advanced Enzymes is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of huge proprietary products developed from various indigenous enzymes & probiotics. The company’s aim is to help consumers’ access side-effect free healthcare, help farmers enhance nutrition for animals, and also to help the industry replace traditional thermal-chemical-mechanical processes into enzyme passed processes.

Business area of the company

The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes. The company products assist its customers in making most of their resources, optimizing their processes, improving their product quality, saving their time and money while also mitigating the impact on the environment. It supplies these value-added and eco-safe enzyme products to diverse end-user industries like human healthcare and nutrition, animal nutrition, food processing, baking, dairy and cheese processing, fruit and vegetable processing, cereal extraction, brewing, grain processing, protein processing, oil and fat processing, biomass processing, textile processing, leather processing, paper & pulp processing, bio-fuels, bio-catalysis etc. Although, the company has the capability to manufacture enzymes using all the four natural origins viz. plant, animal, bacterial and fungal, their major focus is on developing enzymes through microbial fermentation.

Products & Solutions

Human Nutrition: The company’s enzymes are being used by a wide range of customers globally as active ingredients in their pharmaceutical and nutraceutical formulations.

Animal Nutrition: By adding its enzymes to feed, the digestibility of the feed components can be enhanced considerably.

Food Processing: The company’s enzymes play an essential role in bringing more nutrition and appeal to food & beverages products, offering significant benefits beyond the scope of traditional alternatives.

Non-Food Processing: AETL offers eco-safe solutions for a variety of industries such as textiles, leather, detergent, paper & pulp which are used in manufacturing a wide range of products.

Awards

2010: Advanced Enzymes receives Bio-Excellence in Industrial Biotech!
2010: Advanced Enzymes wins the ‘Emerging India Awards 2010’ for Life sciences-Pharmaceuticals & Chemicals segment
2011: Dr. Anil Gupta, General Manager - R&D receives the 2011 Business Leader Award from CHEMTECH foundation
2012: Advanced Enzymes Technologies Limited-received most innovative exporter's award at 'ECGC organized - D&B Indian Exporters Excellence awards.
2013: Advanced Enzymes ranked amongst India’s Fastest-Growing Mid-Sized Cos.
2014: Advanced Enzymes receives Inc. India 500
2014: Advanced Enzymes receives Bio-Excellence in Industrial Biotech
2016: Advanced Enzymes Receives Best Nutraceutical Company of the Year Award
2017: Best IPO Award by IR Society
2018: FE CFO Awards 2018

History and Milestones

1958: Mr. L.C. Rathi sets up India's first enzyme manufacturing plant.
1978: Mr. L.C. Rathi pioneered the production of an enzyme called Papain.
1986L: Acquisition of Super Organic Research Laboratories (SORL) to begin extraction of several commercial enzymes.
1989: Establishment of Rathi Papains Pvt. Ltd. with Mr. L.C.Rathi and Mrs. Savita Rathi as it's founding directors.
1989: Advanced Biochemicals Private Ltd is incorporated to offer global and holistic enzyme solutions.
1991: Advanced Biochemicals commissioned its first fermentation facility at Sinnar, Maharashtra
1992: Advanced Biochemicals is converted from a private company to a public company and renamed as Advanced Biochemicals Limited
1993: Advanced Biochemicals sets up fermentation-based enzyme manufacturing plant with the help of foreign collaboration.
1994: SORL is merged with Advanced Biochemicals Ltd
1996: Advanced Biochemicals sets up a dedicated Application Research facility.
1997: Advanced Biochemicals turns around and reports its first profits.
2001: Advanced Biochemicals' in-house R&D labs at Thane and Sinnar are recognized by the Department of Scientific and Industrial Research (DSIR), Ministry of Science and Technology, Government of India.
2003: Sinnar Factory receives ISO 9001:2000 Systems certification.
2004: Advanced Biochemicals is ranked as the largest domestic manufacturer of Industrial Enzymes.
Advanced Biochemicals files its first patent.
2005: Advanced Biochemicals Limited is renamed as Advanced Enzyme Technologies Limited (or Advanced Enzymes).
2005: Sinnar Factory receives WHO CGMP certification.
2006: Advanced Enzymes acquires 10 Acre land at Pitampur SEZ near Indore to setup state-of-the-art export oriented facility.
2007: Phase I of the export oriented fermentation facility is completed at Pitampur SEZ near Indore.
2008: Advanced Enzytech Solutions Ltd (Enzytech) is established as a subsidiary of Advanced Enzymes to cover non-food processing divisions.
2009: Advanced Enzyme Far East Ltd., a subsidiary of Advanced Enzymes is dedicated to serving the Chinese market.
2010: Advanced Enzymes is honoured with the 'Emerging India Awards 2010' for Life Science - Pharmaceuticals & Chemicals segment organized by ICICI Business Banking and CNBC TV18.
2010: Advanced Enzymes receives the Bio-Excellence 2010 award as the Best Industrial Biotech Company of the year by the department of IT-BT & ST, Govt. of Karnataka.
2011: Advanced Enzymes expands its presence in the US with the takeover of Cal India Foods International (Specialty Enzymes and Biotechnologies) as a step down subsidiary.
2012: Advanced Enzymes consolidates it presence in the US with the take over of Advanced Supplementary Technologies Corporation as a step down subsidiary.
2012: Advanced Enzymes is awarded 1st runner-up as the Most Innovative Exporter by ECGC - D&B Indian Exporters' Excellence Awards 2012.
2012: Phase II of fermentation facility is inaugurated at Pitampur SEZ near Indore.
2012: Advanced Enzymes receives its first US patent.
2013: Advanced Enzymes is ranked amongst the top 500 as part of Inc. India's fastest-growing mid-sized companies' list for 2012.
2014: Advanced Enzymes has received the Bio-Excellence award for being the Best Industrial Biotech Company at Bangalore India Bio 2014 event - the premier Biotechnology event in the country.
2014: Advanced Enzymes is ranked amongst the top 500 of India’s fastest-growing mid-sized companies list for 2013 by Inc. India.
2016: Conducts IPO & lists itself on the Indian Stock Exchanges.
2016: Acquires majority stake in JC Biotech.
2017: Acquired 100% stake in a German based company evoxx technologies GmbH.
2017: GRAS dossier was filed with USFDA
2018: 4 food enzymes got approved as a processing aid with Food Safety Standard Authority of India (FSSAI)
2018: 4 enzymes are registered with REACH –ECHA (European Chemical Agency)